About Us

Prostate cancer

Urothelial cancer

Epidemiology

Functional Urology

Andrology

Pediatric urology

People

Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.

Collaborations

The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

Upcoming Events

The Department of Urology is placed in the Staff Tower (Na buidling), the Erasmus MC Cancer Institute (Be building) and in the research tower (Ee building). The Department Chair is Dr. Joost L. Boormans.

Latest news

Research topics Erasmus MC urothelial cancer research group

Presentation Bladder Cancer Joost Boormans - YouTube  The Erasmus MC Urothelial Cancer Research Group conducts research into the molecular biology...
Read More

Europe’s Beating Cancer Plan brings hope for better prostate cancer outcomes [1]

In February 2021, on the eve of world cancer day, the European Commission presented its Europe’s Beating Cancer Plan, which...
Read More

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Abstract   Background: The optimal interval for repeat biopsy during active surveillance (AS) for prostate cancer is yet to be...
Read More

Waarom hebben mannen steeds slechter zaad?

De vruchtbaarheid van mannen neemt af. Hoe kan dat? In dit college van de Universiteit van Nederland vertelt uroloog Marij...
Read More

Webinar nieuwe ontwikkelingen in Urologische kankerzorg “Gesprekken tussen patiënten & behandelaars”

Bekijk hier de online informatiebijeenkomst voor patiënten met blaaskanker terug van donderdag 17 februari 2022. https://youtu.be/lroJMrA7VrI  
Read More

Interview met Joost Boormans over HPV-vaccinatie bij jongens

Joost Boormans, afdelingshoofd urologie Erasmus MC, werd door de nrc geïnterviewd over HPV-vaccinatie bij jongens. HPV-vaccinatie bij jongens beschermt onder...
Read More

The molecular subtypes of metastatic urothelial carcinoma identified by whole genome and transcriptome sequencing

Researchers from the departments of urology and internal oncology of the Erasmus MC Cancer Institute, in collaboration with Hartwig Medical...
Read More

Four video’s on recent PhD theses have been uploaded to our video page library

Read More

Chemotherapie in spierinvasief blaaskanker

Chemotherapie voorafgaand aan verwijdering van de blaas vanwege spierinvasieve blaaskanker geeft een overlevingswinst op de lange termijn. Deze winst is...
Read More

Extracellular vesicles research in urology and more

In the last months the Laboratory of Experimental Urology published a number of high impact papers on extracellular vesicles in...
Read More

Radiolabeled nanobodies to detect and destroy urothelial carcinoma

The Daniel Den Hoed Foundation, Erasmus MC, awarded a research grant of €500,000 to Prof Guido Jenster (Urology) and Prof...
Read More

Tumor testing for advanced bladder cancer to predict treatment efficacy

The Erasmus Mc Bladder Cancer Centre and VitroScan BV join forces on the EVITA project: “Tumor testing for advanced bladder...
Read More

Towards the development of a catheter decision tool

The functional urology research group was awarded a ZonMw grant to perform a study that will lead to the development...
Read More

 

The full archive can be found by clicking here